全文获取类型
收费全文 | 564251篇 |
免费 | 76389篇 |
国内免费 | 13649篇 |
专业分类
耳鼻咽喉 | 6235篇 |
儿科学 | 17073篇 |
妇产科学 | 5924篇 |
基础医学 | 67690篇 |
口腔科学 | 17892篇 |
临床医学 | 58022篇 |
内科学 | 108739篇 |
皮肤病学 | 9559篇 |
神经病学 | 52206篇 |
特种医学 | 18255篇 |
外国民族医学 | 23篇 |
外科学 | 51738篇 |
综合类 | 67955篇 |
现状与发展 | 53篇 |
一般理论 | 40篇 |
预防医学 | 58673篇 |
眼科学 | 5906篇 |
药学 | 45735篇 |
516篇 | |
中国医学 | 36135篇 |
肿瘤学 | 25920篇 |
出版年
2024年 | 1564篇 |
2023年 | 9157篇 |
2022年 | 17444篇 |
2021年 | 24529篇 |
2020年 | 26927篇 |
2019年 | 30221篇 |
2018年 | 28659篇 |
2017年 | 28299篇 |
2016年 | 27240篇 |
2015年 | 26758篇 |
2014年 | 41112篇 |
2013年 | 43352篇 |
2012年 | 36349篇 |
2011年 | 38666篇 |
2010年 | 31762篇 |
2009年 | 26570篇 |
2008年 | 26520篇 |
2007年 | 24942篇 |
2006年 | 22230篇 |
2005年 | 19039篇 |
2004年 | 16581篇 |
2003年 | 14539篇 |
2002年 | 12160篇 |
2001年 | 10286篇 |
2000年 | 8020篇 |
1999年 | 5958篇 |
1998年 | 5147篇 |
1997年 | 4675篇 |
1996年 | 3986篇 |
1995年 | 3723篇 |
1994年 | 3430篇 |
1993年 | 2942篇 |
1992年 | 2695篇 |
1991年 | 2397篇 |
1990年 | 1990篇 |
1989年 | 1785篇 |
1988年 | 1655篇 |
1987年 | 1466篇 |
1986年 | 1290篇 |
1985年 | 2763篇 |
1984年 | 2822篇 |
1983年 | 1779篇 |
1982年 | 2259篇 |
1981年 | 1635篇 |
1980年 | 1354篇 |
1979年 | 1203篇 |
1978年 | 973篇 |
1977年 | 744篇 |
1976年 | 858篇 |
1975年 | 538篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
73.
74.
75.
76.
77.
John Bickle 《Topics in Cognitive Science》2015,7(2):299-311
David Marr's three-level method for completely understanding a cognitive system and the importance he attaches to the computational level are so familiar as to scarcely need repeating. Fewer seem to recognize that Marr defends his famous method by criticizing the “reductionistic approach.” This sets up a more interesting relationship between Marr and reductionism than is usually acknowledged. I argue that Marr was correct in his criticism of the reductionists of his time—they were only describing (cellular activity), not explaining (cognitive functions). But a careful metascientific account of reductionistic neuroscience over the past two decades reveals that Marr's criticisms no longer have force. Contemporary neuroscience now explains cognition directly, although in a fashion—causal-mechanistically—quite different than Marr recommended. So while Marr was correct to reject the reductionism of his day and offer an alternative method for genuinely explaining cognition, contemporary cognitive scientists now owe us a new defense of Marr's famous method and the advantages of its explanations over the type now pursued successfully in current reductionist neuroscience. There are familiar reasons for thinking that this debt will not be paid easily. 相似文献
78.
Well‐being,health and fitness of children who use wheelchairs: Feasibility study protocol to develop child‐centred ‘keep‐fit’ exercise interventions 下载免费PDF全文
79.
Interprofessional collaboration and communication in nursing homes: a qualitative exploration of problems in medical care for nursing home residents – study protocol 下载免费PDF全文
80.
AimsThe effect of Origanum majorana tea consumption on motor and non-motor symptoms was investigated in patients with idiopathic Parkinson's disease, measured by validated tools.MethodsSixty patients with idiopathic Parkinson's disease and under conventional medication were enrolled voluntarily in the study. All participants were randomized on double-blind to placebo or Origanum majorana. Clinical assessment with validated tools (UPDRSIII, NMSS, and BDI) was done before Origanum majorana or placebo consumption (Day 0) and at the end of the experiment (Day 30).ResultsThe treatment groups were similar at baseline on demographic and clinical variables. During the course of study, nine participants withdrew for reasons of noncompliance and inability to follow-up. Fifty-one participants completed the study. Upon completion of 30 days of treatment, Origanum majorana tea consumption did not decrease the UPDRSIII score ([UPDRSIII] D0 = 18.76 ± 8.58, D30 = 16.52 ± 7.96, p = 0.069) at the p value was 0.07. However, a statistically significant improvement was noted in NMSS and BDI scores (p < 0.0001 and p < 0.0001, respectively). Assessment of the UPDRSIII, NMSS and BDI scores of the patients did not reflect any improvement with placebo. No side effect was detected during the study.ConclusionThese findings show improvement of depressive and non-motor signs in patients with Parkinson's disease in the group that consumed Origanum majorana tea in combination with conventional therapy. Improvement of motor signs may need an extended treatment period. However, more research with a large number of participants and lasting longer than 1 month is needed to argue these findings. 相似文献